semaglutide for ocd helps heart regardless of how much weight lost, study reveals GLP-1 Drug Semaglutide Substantially Reduced

For those concerned about side effects Tirzepatide has the best overall tolerability profile in clinical trials, with the lowest discontinuation rates

Genetic factors affecting GLP-1 receptor sensitivity are an area of ongoing research but currently have limited clinical utility for routine care

Tirzepatide (GLP-1 + GIP receptor agonist), marketed as Mounjaro and Zepbound, has significantly changed how we approach non-surgical weight loss

Regulatory status means more patients have access to the drug, with dosing and safety guidance

Price: $375 per month (Applies while dosage remains at or below 3 mg) Higher-Dose Transition: $490 per month (For patients requiring dosages above 3 mg) Program Includes: Weekly visits, medication management, progress tracking, weight loss coaching, accountability support, and nutritional guidance